Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation; the role of plerixafor

Christos KosmasHematopoietic Cell Transplant Unit, Division of Medical Oncology, Department of Medicine, “Metaxa” Cancer Hospital, Piraeus, Greece; Correspondence[email protected]

http://orcid.org/0000-0001-6790-5785

Eleftheria KranidiotiHematopoietic Cell Transplant Unit, Division of Medical Oncology, Department of Medicine, “Metaxa” Cancer Hospital, Piraeus, Greece;

Aikaterini KosmaHematopoietic Cell Transplant Unit, Division of Medical Oncology, Department of Medicine, “Metaxa” Cancer Hospital, Piraeus, Greece;

Maria KarakostaHematopoietic Cell Transplant Unit, Division of Medical Oncology, Department of Medicine, “Metaxa” Cancer Hospital, Piraeus, Greece;

Constantinos MiltiadousHematopoietic Cell Transplant Unit, Division of Medical Oncology, Department of Medicine, “Metaxa” Cancer Hospital, Piraeus, Greece;

Anastasios GrivasHematopoietic Cell Transplant Unit, Division of Medical Oncology, Department of Medicine, “Metaxa” Cancer Hospital, Piraeus, Greece;

Aggelos AthanasopoulosCryopreservation Laboratory, Blood Transfusion Service, “Metaxa” Cancer Hospital, Piraeus, Greece

Evangelos LianosHematopoietic Cell Transplant Unit, Division of Medical Oncology, Department of Medicine, “Metaxa” Cancer Hospital, Piraeus, Greece;

show all

Click to increase image sizeClick to decrease image size

Acknowledgements

We thank the scientific and technical staff of the Blood Transfusion Service of “Metaxa” Cancer Hospital for hematopoietic stem cell collection and processing.

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article online at http:\\10.1080/10428194.2018.1543879

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation; the role of plerixafor

Information for

Open access

Opportunities

Help and information

Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation; the role of plerixafor

Acknowledgements

Potential conflict of interest:

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature